Molecular and Clinical Oncology Special Issues

Progress in Colorectal Cancer Research

Lead Editor:

    Dr Jun Gong
    Cedars-Sinai Medical Center
    United States

Colorectal cancer remains the third most common cancer diagnosed in men and women globally. Given such a high public burden, there is a global research effort to improve outcomes in colorectal cancer spanning multiple disciplines. Research areas of increasing interest include understanding the biology of young onset colorectal cancer, application of liquid biopsies inclusive of circulating tumor DNA in colorectal cancer management, integration of molecular-guided therapies, to name a few. In this special issue, we invite colleagues from across all disciplines: epidemiology, basic and translational science, genetics, nutrition, surgery, surgical oncology, hematology and oncology, radiation oncology, radiology, interventional radiology, gastroenterology, interventional gastroenterology, palliative care, and pathology to highlight recent advancements in their respective fields that have contributed to the global care of patients with colorectal cancer


Submission deadline: 16 January 2023

Imaging in Prostate Cancer

Lead Editor:

    Dr Yiyan Liu
    Department of Radiology, University of Louisville School of Medicine
    United States

Diagnosis of biochemical recurrence in prostate cancer has been a great challenge for oncologists, urologists and radiologists. There are many updates of the techniques/modalities with novel target molecules in imaging prostate cancer in the recent years. The potential authors are invited to submit the papers which focus on basic science and clinical applications of new image techniques including but not limited to MRI, radionuclide studies and PET/CT with different radiotracers.


Submission deadline: 06 January 2023

Advancement in Cancer: Clinical and Biomarker

Lead Editor:

    Professor Abrar Hussain
    BUITEMS
    Pakistan

The first and far most challenge in cancer treatment is its diagnosis at very early stage. Once early diagnosis is done, further treatment and management is possible. With advancement of tools for detection of cancer as compare to fifty years back has lead to its better treatment. Artificial Intelligence use in computer software and Circ RNA databases has increased our understanding in the area of clinical and biomarker of cancer


Submission deadline: 22 December 2022

Journal Cover

December-2022
Volume 17 Issue 6

Print ISSN: 2049-9450
Online ISSN: 2049-9469

Sign up for eToc alerts

Recommend to Library

Full Size Image